戻る Agenda
Advancing effective use of digital health technologies in Parkinson’s Disease
Session Chair(s)
Joseph Scheeren, PHARMD
Founder
Scheeren HealthCare LLC, United States
This session proposes to highlight the utility of employing digital health technologies to define disease trajectories, monitor disease progression and assess therapeutic response to novel therapies candidates for Parkinson’s.
Speaker(s)
Panelist
Lauren Oliva, PHARMD, RPH
Biogen, United States
US Regulatory Policy Lead
Panelist
Babak Boroojerdi, DrMed, MBA
UCB Biosciences, Germany
Global Program Physician, Rare Disease Organization
Panelist
Steve Ford
Parkinson’s UK, United Kingdom
Chief Executive Officer